T 0620/08 (Oxo-pyridine/ENCYSIVE) du 04.05.2011
- Identifiant européen de la jurisprudence
- ECLI:EP:BA:2011:T062008.20110504
- Date de la décision
- 4 mai 2011
- Numéro de l'affaire
- T 0620/08
- Requête en révision de
- -
- Numéro de la demande
- 00930450.2
- Classe de la CIB
- C07D 405/12
- Langue de la procédure
- Anglais
- Distribution
- Distribuées aux présidents des chambres de recours (C)
- Téléchargement
- Décision en anglais
- Versions JO
- Aucun lien JO trouvé
- Autres décisions pour cet affaire
- -
- Résumés pour cette décision
- -
- Titre de la demande
- Propanoic acid derivatives that inhibit the binding of integrins to their receptors
- Nom du demandeur
- ENCYSIVE PHARMACEUTICALS, INC.
- Nom de l'opposant
- Vertex Pharmaceuticals Incorporated
- Chambre
- 3.3.01
- Sommaire
- -
- Dispositions juridiques pertinentes
- European Patent Convention Art 54European Patent Convention Art 56European Patent Convention Art 84
- Mots-clés
- Admissibility of documents late-filed during opposition proceedings: (yes) partly
Late-filed ground for opposition - considered
Main, first and second auxiliary request: novelty (no) special - meaning of terms used in patent specification considered
Adjournment of oral proceedings (no) - no new issues
Fourth auxiliary request: novelty (yes); inventive step (yes) - oxo-pyridine compounds non-obvious alternative - Exergue
- -
ORDER
For these reasons it is decided that:
1. The decision under appeal is set aside.
2. The case is remitted to the department of first instance with the order to maintain the patent on the basis of the fourth auxiliary request filed during the oral proceedings on 4 May 2011:
- Description: - page 8 as filed during the oral
proceedings on 4 May 2011
- pages 3-7 and 9-25 of the patent
specification.
- Claims: Claim 1-9 as filed during the oral
proceedings on 4 May 2011